<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04812795</url>
  </required_header>
  <id_info>
    <org_study_id>843579</org_study_id>
    <secondary_id>R01CA237670</secondary_id>
    <nct_id>NCT04812795</nct_id>
  </id_info>
  <brief_title>Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches</brief_title>
  <acronym>RESIST</acronym>
  <official_title>Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Michigan State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard School of Public Health (HSPH)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fenway Community Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Project RESIST is an R01 study funded by NCI focused on determining the effects of using&#xD;
      culturally tailored inoculation approaches to increase resilience to tobacco marketing&#xD;
      influences among young adult sexual minority women ages 18-30 and incorporates critical&#xD;
      stakeholder inputs that support later adoption and implementation. The study team is&#xD;
      utilizing formative research to design and pre-test anti-smoking messages and two national&#xD;
      longitudinal online survey experiments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will recruit 2000 young adult sexual minority women (SMW), ages 18-30 years,&#xD;
      current smokers (n = 1000) and not current smokers (n=1000). The study team will randomly&#xD;
      assign participants to a condition in which they will be exposed to either culturally&#xD;
      tailored anti-smoking messages or non-tailored. Participants will receive these messages at&#xD;
      baseline and 1, 2, and 3 weeks post baseline. They will be asked to complete a follow-up&#xD;
      survey one month post baseline. Intentions to quit smoking as well as intention (among&#xD;
      current smokers) and intention to purchase cigarettes (among current nonsmokers) will be&#xD;
      measured at baseline and one-month post baseline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">September 8, 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly assigned to the tailored or non-tailored arms using random assignment function within survey software.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in intention to quit smoking</measure>
    <time_frame>Days 0, 30</time_frame>
    <description>Change in intention to quit smoking will be measured using the Burkhalter intention to quit smoking four item scale that measures readiness to cut down or quit smoking in the next 30 days. This will only be measured among current smokers. Lowest mean score is 1 and highest mean score is 7. Higher scores indicate increased intention to quit smoking.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in intention to purchase cigarettes</measure>
    <time_frame>Days 0, 30</time_frame>
    <description>Change in intention to purchase cigarettes will be measured using the Juster single item consumer buying intention scale to measure how likely participants who are not current smokers are to purchase cigarettes. Response options range from 0 to 10 with 10 indicating a higher likelihood of purchasing cigarettes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Cigarette Smoking Behavior</condition>
  <arm_group>
    <arm_group_label>Culturally tailored</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The anti-smoking and anti-industry messages will be culturally tailored to specifically reach out to young adult SMW. They will receive only messages that are culturally tailored at baseline and weeks 1, 2, and 3.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-culturally tailored</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The anti-smoking and anti-industry messages will not be culturally tailored. They will receive only messages that are not culturally tailored at baseline and weeks 1, 2 and 3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Culturally tailored anti-smoking messages</intervention_name>
    <description>Anti-smoking messages that are culturally tailored for sexual minority women.</description>
    <arm_group_label>Culturally tailored</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-culturally tailored interventions</intervention_name>
    <description>Anti-smoking messages that are not culturally tailored for sexual minority women.</description>
    <arm_group_label>Non-culturally tailored</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 18-30&#xD;
&#xD;
          -  Woman&#xD;
&#xD;
          -  Identifies as a sexual minority (any sexual orientation other than heterosexual)&#xD;
&#xD;
          -  Lives in the United States&#xD;
&#xD;
          -  Able to take surveys in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 or older than 30&#xD;
&#xD;
          -  Men&#xD;
&#xD;
          -  Heterosexual&#xD;
&#xD;
          -  Lives outside the United States&#xD;
&#xD;
          -  Unable to take survey in English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Anyone who identifies as a woman, whether they are cisgender or transgender, would meet the gender-based eligibility requirement.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 9, 2021</study_first_submitted>
  <study_first_submitted_qc>March 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Andy Tan, PhD, MBA, MPH, MBBS</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

